Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Chiesi USA
Advances in™ Beta-Thalassemia: The Evolving Therapeutic Landscape
.png)
Release Date: December 22, 2021
Expiration Date: December 22, 2022
Activity Overview
Acknowledgement of Commercial Support
This activity is supported by an educational grant from Chiesi USA
Instructions for This Activity and Receiving Credit
You may immediately download your certificate. |
Target Audience
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Understand the pathophysiology of iron overload in β-thalassemia
- Identify patients with iron overload in patients with β-thalassemia
- Apply current guidelines for the management of β-thalassemia
- Assess clinical trial data for safety and efficacy of new and emerging therapies for β-thalassemia
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
Faculty
George H. Kitzman Professor of Genetics
Chief, Division of Cellular and Molecular Therapy
Departments of Pediatrics and Molecular Genetics & Microbiology
University of Florida College of Medicine
Gainesville, FL
Disclosures: Grant/Research Support: Aavanti Bio, Kitzman Foundation, National Institutes of Health, Pfizer, Sarepta Therapeutics; Consultant: AgeX Therapeutics, Passage Bio; Stock/Shareholder: Lacerta Therapeutics
Assistant Professor of Medicine
Harvard Medical School
Classical Hematologist and Clinical Investigator
Division of Hematology Oncology
Massachusetts General Hospital
Boston, MA
Disclosures: Grant/Research Support: Agios Pharmaceuticals, Amgen, Dova/Sobi; Consultant: Agios, Argenx, Dova/Sobi, Forma Therapeutics, Moderna, Novartis, Rigel Pharmaceuticals.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
Login or Register to Start Activity
Please use the form below to Register or Log In to begin Activity.
